Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors

被引:121
作者
Holladay, MW [1 ]
Wasicak, JT [1 ]
Lin, NH [1 ]
He, Y [1 ]
Ryther, KB [1 ]
Bannon, AW [1 ]
Buckley, MJ [1 ]
Kim, DJB [1 ]
Decker, MW [1 ]
Anderson, DJ [1 ]
Campbell, JE [1 ]
Kuntzweiler, TA [1 ]
Donnelly-Roberts, DL [1 ]
Piattoni-Kaplan, M [1 ]
Briggs, CA [1 ]
Williams, M [1 ]
Arneric, SP [1 ]
机构
[1] Abbott Labs, Neurol & Urol Dis Res D47W, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm9706224
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New members of a previously reported series of 3-pyridyl ether compounds are disclosed as novel, potent analgesic agents acting through neuronal nicotinic acetylcholine receptors. Both (R)-2-chloro-5-(2-azetidinylmethoxy)pyridine (ABT-594, 5) and its S-enantiomer (4) show potent analgesic activity in the mouse hot-plate assay following either intraperitoneal (ip) or oral (po) administration, as well as activity in the mouse abdominal constriction (writhing) assay, a model of persistent pain. Compared to the S-enantiomer and to the prototypical potent nicotinic analgesic agent (+/-)-epibatidine, 5 shows diminished activity in models of peripheral side effects. Structure-activity studies of analogues related to 4 and 5 suggest that the N-unsubstituted azetidine moiety and the 2-chloro substituent on the pyridine ring are important contributors to potent analgesic activity.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 31 条
  • [21] THE HEALTH CONSEQUENCES OF SMOKING - CARDIOVASCULAR-DISEASES
    MCBRIDE, PE
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1992, 76 (02) : 333 - 353
  • [22] PABREZA LA, 1990, MOL PHARMACOL, V39, P9
  • [23] QIAN CG, 1993, EUR J PHARMACOL, V250, pR13
  • [24] Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay
    Rao, TS
    Correa, LD
    Reid, RT
    Lloyd, GK
    [J]. NEUROPHARMACOLOGY, 1996, 35 (04) : 393 - 405
  • [25] EPIBATIDINE - A NOVEL (CHLOROPYRIDYL)AZABICYCLOHEPTANE WITH POTENT ANALGESIC ACTIVITY FROM AN ECUADORIAN POISON FROG
    SPANDE, TF
    GARRAFFO, HM
    EDWARDS, MW
    YEH, HJC
    PANNELL, L
    DALY, JW
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (09) : 3475 - 3478
  • [26] SULLIVAN JP, 1994, J PHARMACOL EXP THER, V271, P624
  • [27] A-85380 [3-(2(S)-azetidinylmethoxy)pyridine]: In vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand
    Sullivan, JP
    DonnellyRoberts, D
    Briggs, CA
    Anderson, DJ
    Gopalakrishnan, M
    PiattoniKaplan, M
    Campbell, JE
    McKenna, DG
    Molinari, E
    Hettinger, AM
    Garvey, DS
    Wasicak, JT
    Holladay, MW
    Williams, M
    Arneric, SP
    [J]. NEUROPHARMACOLOGY, 1996, 35 (06) : 725 - 734
  • [28] Sullivan JP, 1997, J PHARMACOL EXP THER, V283, P235
  • [29] SULLIVAN JP, 1996, CNS DRUG REV, V2, P21
  • [30] SULLIVAN JP, 1994, MED CHEM RES, V4, P502